About Broad Street Alerts:
Big opportunities in Small Cap’s
Broadstreetalerts.com recent profiles and track record, 157% in verifiable potential gains for our
members in December 2015 alone.
December 29th, 2015- (NASDAQ: INVT) opened $1.35/share hit a high midday of $2.82/share over 100%
in gains for our members.
December 15th, 2015-(NYSE-MKT: XXII) opened at $1.29 hit a high of $1.54 within 3 days for gains of
19% for our members.
December 2nd, 2015- (NASDAQ: TCCO) opened at $3.25 hit a high of $4.50 within 3 days for 38% gains
for our members.
These are numbers that make traders drool. Any trader in any market would fall all over themselves to
see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and
verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest
of the small-cap newsletters as the best in business. We know with a large following comes a large
responsibility as we have everyone from institutional investors to the beginner following our profiled
securities in our newsletters. This is something we take very seriously always seeking small cap growth
companies that have both near and long-term potential for our members.
***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our
VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your
cell phone.
Breathe Right Nasal Strips Powerhouse Dr. Dan Cohen Named Airware Labs President
Aug 19, 2015
OTC Disclosure & News Service
–
Airware Labs Corporation (OTCQB: AIRW) today announced the appointment of Dr. Dan Cohen to the newly created position of President of Airware Labs Corporation. CEO Jeffrey Rassas said the appointment becomes effective immediately.
Dr. Cohen is the former Founder, Chairman and CEO of CNS, Inc. Dr. Cohen was the driving force behind the meteoric rise of Breathe Right nasal strips, acquiring the rights to manufacture and sell the product for the medical equipment company he founded in 1982. With the successful drive to achieve FDA approval for marketing of the largely unknown product and with all of the top ten pharmaceutical wholesalers on board, Cohen launched a legendary marketing effort to generate market awareness. His efforts created an outcry of domestic and international consumer demand that rocketed CNS sales to a 77% increase as the company took the public spotlight and was named Fortune magazine’s fourth fastest growing company in the U.S. in 1996. In 2006, GlaxoSmithKline acquired CNS, including its Breathe Right nasal strips and FiberChoice™ chewable fiber supplement products, for $566 million
“Dan Cohen’s strategic vision and his well-known track record as an innovator make him the right choice for the next phase of development for Airware Labs. This is an exciting time as we see expanding product traction in domestic and international markets. Our growing success in increasing consumer brand awareness and the availability of our products in consumer-preferred brick and mortar and online retail outlets points to what I expect will be an increasingly bright and profitable future,” said Airware Labs Corporation CEO Jeffrey Rassas.
Dr. Cohen is a board certified neurologist and an accomplished entrepreneur. In addition to CNS, Inc., he is also the co-founder of Round River Research Corporation and the inventor of patented technology used for stress reduction and personal development. Dr. Cohen holds numerous patents related to EEG signal processing, physiologic analysis algorithms and additional utility patents related to synchronized sound, vibration and electromagnetic fields and their effect on the body and mind.
Airware Labs’ products are marketed under the brand name of AIR™ and address key consumer health and quality of life challenges including snoring, insomnia, nausea, headaches, airborne bacteria and viruses, allergies, congestion, and enhanced sports performance. Unlike external products such as nasal strips, these soft, comfortable, and discreet, latex and drug free products fit just inside the nose utilizing an FDA approved medical grade material. Nearly invisible for use anytime and anywhere, the AIR™ products’ microstructure enhances normal nasal airflow with every breath. Some Airware products include 3M filtration media to stop allergens, airborne bacteria and viruses as well as a blend of proven, therapeutic premium oils to provide additional antimicrobial protection and symptomatic relief.
Airware Labs most recently announced the availability of its AIR™ Defense product in South Korea marking another milestone in its growing success in expanding product sales in international as well as domestic markets. In recent months, Airware Labs announced prestigious retail outlets in India and China are now selling Airware Labs’ products. Domestically, the Company’s pioneering products are available through a number of brick and mortar retail locations including Walgreens, Albertsons, Acme, Shoppers, Shop n’ Save, ACME, and Farm Fresh along with individual distributors in the United States, Canada, and Europe. Online the products are available at a variety of retail sites including Walmart, Walgreens, Target, Drugstore.com, CVS, Amazon and Airware Labs.
About Airware Labs Corporation: Airware Labs Corp. (publicly traded as OTCQB: AIRW) provides patented, innovative breathing technology products that promote better health and enhanced wellbeing in addition to a new line of skin care products. The company is headquartered in Scottsdale, Arizona. Explore our extensive product line at http://www.airwarelabs.com and learn more about our company by visiting http://airwarelabscorp.com.
Forward-Looking Statement: The statements in this press release regarding any implied or perceived benefits from the release by Airware Labs Corp. of its products are forward-looking statements. Such statements involve risks and uncertainties, including, but not limited to, risks and effects of legal and administrative proceedings and governmental regulation, especially in a foreign country, future financial and operational results, competition, general economic conditions, and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include the introduction of new technology, market conditions and those set forth in reports or documents we file from time to time with the SEC. We undertake no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Source-OTCMARKETS
